「ag」の検索結果
43件：21～25件目を表示
-
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
quarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: To...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
临床试验信息 | 研究与开发 | 千寿制药株式会社
te that the information may differ from the up-to-date information depending on when it is updated. Agree Disagree
https://www.senju.co.jp/chinese/rd/trial.html -
Quality Policies | About Senju | SENJU Pharmaceutical
t the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realization of p...
http://www.senju.co.jp/english/about/quality.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Ats...
http://www.senju.co.jp/english/rd/society/